S.-Ja Tseng
Name
S.-Ja Tseng
Title
Associate Professor
TEL
886-6 235-3535 ext 5469/5473
FAX
886-6 274-9296
|
Research Focus |
|---|
|
In October 2015, the U.S. Food and Drug Administration approved the first clinical virotherapy for cancer treatment. However, this therapy was limited to intra-tumoral injection, restricting its broader application across different tumor types. Acknowledging this limitation, our team is dedicated to advancing virotherapy by addressing the challenges of systemic delivery. Through innovative approaches such as chemical modifications, antibody engineering, and nanotechnology, we aim to improve the stability and effectiveness of viral therapies during circulation. These enhancements will enable more efficient delivery to tumors throughout the body, expanding the treatment's therapeutic potential and overall efficacy. |
|
Collaborating Laboratories |
|
|---|---|
|
Dr. Ivan M. Kempson, University of South Australia Dr. Da-Liang Ou, National Taiwan University College of Medicine Dr. Pan-Chyr Yang, National Taiwan University College of Medicine Dr. Zi-Xian Liao, National Sun Yat-sen University
|
|
Honor |
|
|---|---|
|
Wu Ho-Su TBF Medical Award, Taiwan Bio-development Foundation (2021) Young Scholar Innovation Award, Foundation for the Advancement of Outstanding Scholarship (2017) 14th Y. Z. Hsu Scientific Paper Award (Nano Science & Technology) (2016) Postdoctoral Academic Publication Award, Ministry of Science and Technology (2014) Technology Research Scholarship, CTCI Foundation, Taiwan (2009) |
|
Recent Publications
|
|
|---|---|
|
|
Selected Publications |
|
|---|---|